Paris, France

Cosima Dufour-Schroif


 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Cosima Dufour-Schroif: Innovator in Pharmaceutical Chemistry

Introduction

Cosima Dufour-Schroif is a prominent inventor based in Paris, France. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. Her work focuses on addressing bacterial infections through innovative chemical solutions.

Latest Patents

Dufour-Schroif holds a patent for "Streptospirole derivatives." This invention relates to streptospirole derivatives of the general formula (I), wherein R, R, R, X, X, Y, and Y are defined within the patent. The process involves fermenting the microorganism sp. ST 108140 (DSM 19369) and optionally derivatizing the compounds produced by this microorganism. Additionally, the patent includes a pharmaceutical composition comprising at least one compound of the formula (I) and outlines the use of these compounds for the preparation of a medicament aimed at treating and/or preventing bacterial infections. She has 1 patent to her name.

Career Highlights

Cosima Dufour-Schroif is currently employed at Sanofi, a leading global healthcare company. Her role involves extensive research and development in the pharmaceutical sector, where she applies her expertise to create effective treatments for various health conditions.

Collaborations

Throughout her career, Dufour-Schroif has collaborated with notable colleagues, including Joachim Wink and Martin Gerlitz. These partnerships have enhanced her research efforts and contributed to the advancement of her innovative projects.

Conclusion

Cosima Dufour-Schroif exemplifies the impact of innovation in pharmaceutical chemistry. Her dedication to developing new treatments for bacterial infections showcases the importance of research and collaboration in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…